Consistently with these reports, we found that TGFB1 was markedly upregulated in the invasive sublines (Figure 3), overexpressed in the cancer tissues (Figure 4F), and associated with poor prognosis in HNC patients (Figure 4A). The gene discussed is TGFB1; the disease is cancer.